Medicine & TechnologyThrough a randomized, double-blind, placebo-controlled clinical trial, researchers at Brigham and Women's Hospital discovered that the insomnia drug suvorexant developed by Merck & Co., was safe and effective, improving insomnia and night sweats in peri- and postmenopausal women.